Heal the heart. Protect the brain.
Press Kit

News/Press Releases

May 10, 2012 SeptRx Intrapocket PFO Occluder (IPO) will be presented from the podium at "EuroPCR 2012" (PDF - 152 KB)

April 23, 2012 SeptRx completes enrollment for its "InterSEPT" CE mark trial, partners with CoRRect Medical GmbH for European distribution of its SeptRx Intrapocket PFO Occluder (IPO) (PDF - 152 KB)

January 3, 2012 SeptRx reports first 20 patients have been enrolled in its "InterSEPT" CE Mark trial of the SeptRx® Intrapocket PFO Occluder (IPO) (PDF - 147 KB)

June 16, 2011 SeptRx begins CE Mark trial of the SeptRx® Intrapocket PFO Occluder (IPO) (PDF - 147 KB)

June 6, 2011 SeptRx receives 'Series A' to fund CE Mark trial of the SeptRx® Intrapocket PFO Occluder (IPO) (PDF - 156 KB)

Publications

Wibke J. Zimmermann, MD, Corinna Heinisch, MD, Nicolas Majunke, MD, Stephan Staubach, MD, Scott Russell, Nina Wunderlich, MD, Horst Sievert, MD, "Patent Foramen Ovale Closure With the SeptRx Device: Initial Experience With the First "In-Tunnel" Device", J Am Coll Cardiol Intv, 2010; 3:963-967.

All content on this site is the copyright of SeptRx, Inc. All rights reserved.